Taking all this into consideration, in this study we aimed to evaluate for the first time the role of irisin as a genetic and serological biomarker of subclinical atherosclerosis and CV risk in a large cohort of Caucasian patients with axSpA. Here, FNDC5 is linked to atherosclerosis.